Diego Malón

Pretreatment neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte, and neutrophil/monocyte ratios and outcome in elderly breast cancer patients

Beatriz Losada, Juan Antonio Guerra, Diego Malón et al. · Clinical & Translational Oncology · 2018 · 65 citations

Breast Oncology, Medicine, Pretreatment Neutrophil/lymphocyte +7

Randomized Phase 0/I Trial of the Mitochondrial Inhibitor ME-344 or Placebo Added to Bevacizumab in Early HER2-Negative Breast Cancer

Miguel Quintela-Fandiño, Serafín Morales, Alfonso Cortés-Salgado et al. · Clinical Cancer Research · 2019 · 43 citations

Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial

Miguel Quintela-Fandiño, Esther Holgado, Luís Manso et al. · Breast Cancer Research · 2020 · 28 citations · Full text

Assessment of a Genomic Assay in Patients With <i>ERBB2</i>-Positive Breast Cancer Following Neoadjuvant Trastuzumab-Based Chemotherapy With or Without Pertuzumab

Coralia Bueno, Isabel Echavarría, Sara López‐Tarruella et al. · JAMA Oncology · 2023 · 28 citations · Full text

Nintedanib plus letrozole in early breast cancer: a phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition

Miguel Quintela-Fandiño, Juan V. Apala, Diego Malón et al. · Breast Cancer Research · 2019 · 22 citations · Full text